TEVA

Teva Pharmaceutical Industries Limited

17.16 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Teva Pharmaceutical Industries Limited stock is up 5.34% since 30 days ago. The next earnings date is Jul 31, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 54.29% of the previous 34 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
11 Jun 17:01 17 Jan, 2025 16.00 CALL 80 3280
11 Jun 17:35 16 Jan, 2026 32.00 CALL 700 252
11 Jun 17:46 17 Jan, 2025 21.00 CALL 270 102
11 Jun 17:50 17 Jan, 2025 10.00 CALL 108 9839
11 Jun 19:57 17 Jan, 2025 16.00 CALL 100 3280
12 Jun 14:08 20 Sep, 2024 16.00 CALL 200 37216
12 Jun 14:23 21 Jun, 2024 13.00 CALL 500 82219
12 Jun 17:19 17 Jan, 2025 14.00 PUT 1000 4548
14 Jun 16:02 16 Jan, 2026 4.00 CALL 20 71
14 Jun 18:31 20 Sep, 2024 16.00 CALL 362 37035

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited sells generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. Its products in the central nervous system, pain, respiratory, and oncology areas include Copaxone for the treatment of relapsing forms of multiple sclerosis. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

  • Barclays
    Wed Jun 5, 11:19
    buy
    confirm
  • Bank of America
    Thu May 30, 11:44
    buy
    confirm